Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2024

31-10-2023 | Back Pain | Letter to the Editor

Yoga Versus Education for Veterans with Chronic Low Back Pain

Authors: Eric J. Roseen, DC PhD, Janice Weinberg, ScD, Robert B. Saper, MD MPH

Published in: Journal of General Internal Medicine | Issue 1/2024

Login to get access

Excerpt

Our study1 found that 12-weekly hatha yoga classes were not more effective than an education intervention for improving pain and disability outcomes among 120 Veterans with chronic low back pain (cLBP). We appreciate Dr. Ozden’s comments regarding important methodologic considerations for studies of complex nonpharmacologic or behavioral interventions for cLBP. Blinding of participants to treatment allocation in a study of yoga vs. education is unfortunately not possible. However, we followed recommended guidelines for blinding those who collected, handled, or analyzed data to treatment group allocation.2 We opted not to report p-values in Table 1 based on guidelines that discourage the use of p-values to assess baseline differences in parallel group randomized trials.1, 3, 4 We identified one baseline difference between groups of a clinically important prognostic factor (opioid use) which we adjusted for in our analyses. Also, Dr. Ozden highlights our multiple time points of data capture and recommends assessments for change at different time points. We had evaluated changes at additional endpoints with similar results, i.e., no between-group differences in primary outcomes at 6 and 24 weeks (shown in Appendix Tables 2 and 3 of previously published manuscript).1 Furthermore, we used effect estimates and their 95% confidence intervals rather than p-values to interpret findings.3 Lastly, they raise the important point of whether patients with specific causes of back pain (e.g., stenosis, radiculopathy) were included. We identified Veterans with cLBP pragmatically using ICD diagnostic codes documented in health records, self-report of at least 12-week duration of pain, and current pain intensity at least 4 of 10 on the Defense and Veterans Pain Rating Scale. Participants answered screening questions on “red flags” to rule out serious specific causes of cLBP but were not required to have physical examinations or advanced imaging prior to enrollment. While this would have excluded most individuals with back pain due to fracture, cancer, infection, or severe spinal canal stenosis, heterogeneity of back pain subtypes is likely although this is a common challenge in cLBP intervention studies. Older age, male sex, and having more comorbid physical and mental health conditions have been found to be predictors of non-response to yoga.5 The negative findings of our trial in Veterans may be related to this.1 Understanding the mechanisms underlying non-response and how to optimize yoga interventions for these individuals are fruitful areas of future study. …
Literature
Metadata
Title
Yoga Versus Education for Veterans with Chronic Low Back Pain
Authors
Eric J. Roseen, DC PhD
Janice Weinberg, ScD
Robert B. Saper, MD MPH
Publication date
31-10-2023
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 1/2024
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08447-2

Other articles of this Issue 1/2024

Journal of General Internal Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine